IFNB1 and multiple sclerosis: Thus, it is plausible that the positive immunomodulatory effects of interferon beta (IFNβ) as seen in an inflammatory environment such as multiple sclerosis (MS) will also have a therapeutic effect in the neonatal HIE model.